Photo of Xiaodong Luo

Xiaodong Luo

Print ProfilePrint Profile


    Since joining MSSM, I have been working in Alzheimer's disease research center in the Department of Psychiatry, where my responsibility is to provide statistical consultation for study design.

    My research interests are in Survival analysis, Longitudinal data analysis, Non-parametric statistical methods and Incomplete data analysis as well as application of these methods in clinical research.

    Keywords:  Alzheimer's disease, Survival analysis, Longitudinal data analysis, Non-parametric statistical methods, Incomplete data analysis


Luo X, Tsai WY. Nonparametric estimation of bivariate distribution under right truncation with application to panic disorder. Journal of Statistical Planning and Inference 2008;.

Sano M, Andrews H, Karen B, Neill GL, Peter R, Karen B, Tsai WY, Peter C, Karen A, Rosann C, Luo X. A multi-center, randomized, double blind placebo controlled trial of estrogens to prevent Alzheimer's disease and loss of memory in women: Design and baseline characteristics. Clinical Trials: Journal of the Society for Clinical Trials 2008;.

Wang S, Jacobs D, Andrews H, Tsai WY, Luo X, Bergmann C, Sano M. Cardiovascular risk and memory in non-demented elderly women. Neurobiology of Aging 2008;.

Wright CB, Elkind MV, Luo X, Paik MC, Sacco RL. Reported Alcohol consumption and cognitive decline: the Northern Manhattan Study. Neuroepidemiology 2006; 27: 201-207.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Luo did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central